AAPM

Roundup: Analgesic efficacy of Milnacipran; tolerability of Tapentadol; efficacy/safety of Tapentadol; epidural steroid injection; outcomes in osteoarthritis.

Roundup: PAIN BLITZ pilot project; dose stability of Tapentadol ER; failed back surgery syndrome; sympathetic nerve block; combined radiofrequency ablation.

Roundup: Neuropathic cancer pain; spinal/peripheral neuromodulation; comorbid depressive disorder; morphine and prialt IT therapies; spinal cord stimulation.

A lively question and answer session follows a pro and con debate on the use of opioids.

A study of the costs of targeted medicine delivery systems, and an analysis of the differences between the costs of treatment for chronic pain treatments.

A study of minimally invasive facet arthrodesis and spinal cord stimulation show they can achieve relief for patients with back pain.

Roundup: Safety and efficacy of Diclofenac; effect of Duloxetine; MIS non-instrumented facet arthodesis; paresthesia coverage; and Milnacipran for fibromyalgia.

A frank discussion of healthcare reform and its expected effects on the practice of pain medicine.

A debate over whether the use of prescription opioids is really the most effective method of pain control.

A 10-year study showed that whle methadone represented less than 5% of all opioid prescriptions, it was responsible for a third of the deaths.

Doctors showed positive results of peripheral nerve stimulation in a patient suffering from pain after a herpes breakout.

Tanezumab, a monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions.

Recent court rulings have grown in prominence because the Obama administration has taken a more tolerant stance toward the use of medical marijuana.

The efforts by the government to thwart drug abusers have dramatically increased the chances that a physician will face criminal complaints.

Sign up now for a reminder about our live coverage of the conference.